BBC vs. FHLC
BBC (Virtus LifeSci Biotech Clinical Trials ETF) and FHLC (Fidelity MSCI Health Care Index ETF) are both Health & Biotech Equities funds - BBC tracks the LifeSci Biotechnology Clinical Trials Index while FHLC tracks the MSCI USA IMI Health Care Index. Both are passively managed. Over the past 10 years, BBC returned 7.60%/yr vs 9.05%/yr for FHLC. A 0.61 correlation means they provide meaningful diversification when combined. BBC charges 0.79%/yr vs 0.08%/yr for FHLC.
Performance
BBC vs. FHLC - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, BBC achieves a 8.17% return, which is significantly higher than FHLC's -4.68% return. Over the past 10 years, BBC has underperformed FHLC with an annualized return of 7.60%, while FHLC has yielded a comparatively higher 9.05% annualized return.
BBC
- 1D
- -4.90%
- 1M
- -4.81%
- YTD
- 8.17%
- 6M
- 20.12%
- 1Y
- 123.11%
- 3Y*
- 19.82%
- 5Y*
- -2.05%
- 10Y*
- 7.60%
FHLC
- 1D
- -1.25%
- 1M
- 0.66%
- YTD
- -4.68%
- 6M
- -4.34%
- 1Y
- 13.84%
- 3Y*
- 5.85%
- 5Y*
- 4.42%
- 10Y*
- 9.05%
BBC vs. FHLC - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
BBC Virtus LifeSci Biotech Clinical Trials ETF | 8.17% | 63.77% | -1.11% | -1.80% | -35.13% | -22.31% | 30.32% | 63.81% | -18.29% | 57.85% |
FHLC Fidelity MSCI Health Care Index ETF | -4.68% | 15.42% | 2.48% | 2.58% | -5.55% | 20.39% | 18.13% | 21.94% | 4.71% | 23.34% |
Correlation
The correlation between BBC and FHLC is 0.49, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.49 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.51 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.55 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.59 |
Correlation (All Time) Calculated using the full available price history since Dec 18, 2014 | 0.61 |
The correlation between BBC and FHLC shifts across timeframes, from 0.49 (1 year) to 0.61 (all time), reflecting how their relationship changes across market environments.
BBC vs. FHLC - Sectors Allocation Comparison
Sectors
BBC
FHLC
Healthcare
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Financial Services
-
Industrials
-
Real Estate
-
-
Technology
-
Utilities
-
-
Healthcare
BBC
FHLC
Basic Materials
BBC
-
FHLC
-
Communication Services
BBC
-
FHLC
-
Consumer Cyclical
BBC
-
FHLC
-
Consumer Defensive
BBC
-
FHLC
-
Energy
BBC
-
FHLC
-
Financial Services
BBC
-
FHLC
Industrials
BBC
-
FHLC
Real Estate
BBC
-
FHLC
-
Technology
BBC
-
FHLC
Utilities
BBC
-
FHLC
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BBC vs. FHLC — Risk / Return Rank
BBC
FHLC
BBC vs. FHLC - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Virtus LifeSci Biotech Clinical Trials ETF (BBC) and Fidelity MSCI Health Care Index ETF (FHLC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| BBC | FHLC | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 3.49 | 0.97 | +2.52 |
Sortino ratioReturn per unit of downside risk | 4.11 | 1.52 | +2.59 |
Omega ratioGain probability vs. loss probability | 1.48 | 1.17 | +0.31 |
Calmar ratioReturn relative to maximum drawdown | 8.82 | 1.35 | +7.47 |
Martin ratioReturn relative to average drawdown | 28.55 | 3.44 | +25.12 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| BBC | FHLC | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 3.49 | 0.97 | +2.52 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.05 | 0.30 | -0.35 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.20 | 0.54 | -0.34 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.12 | 0.60 | -0.49 |
Drawdowns
BBC vs. FHLC - Drawdown Comparison
The maximum BBC drawdown since its inception was -76.85%, which is greater than FHLC's maximum drawdown of -28.76%. Use the drawdown chart below to compare losses from any high point for BBC and FHLC.
Loading charts...
Drawdown Indicators
| BBC | FHLC | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -76.85% | -28.76% | -48.09% |
Max Drawdown (1Y)Largest decline over 1 year | -15.10% | -10.38% | -4.72% |
Max Drawdown (3Y)Largest decline over 3 years | -54.45% | -16.87% | -37.58% |
Max Drawdown (5Y)Largest decline over 5 years | -72.44% | -17.73% | -54.71% |
Max Drawdown (10Y)Largest decline over 10 years | -76.85% | -28.76% | -48.09% |
Current DrawdownCurrent decline from peak | -30.57% | -7.71% | -22.86% |
Average DrawdownAverage peak-to-trough decline | -37.14% | -5.19% | -31.95% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.66% | 4.09% | +0.57% |
Volatility
BBC vs. FHLC - Volatility Comparison
Virtus LifeSci Biotech Clinical Trials ETF (BBC) has a higher volatility of 11.21% compared to Fidelity MSCI Health Care Index ETF (FHLC) at 3.97%. This indicates that BBC's price experiences larger fluctuations and is considered to be riskier than FHLC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BBC | FHLC | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.21% | 3.97% | +7.24% |
Volatility (6M)Calculated over the trailing 6-month period | 26.65% | 10.17% | +16.48% |
Volatility (1Y)Calculated over the trailing 1-year period | 35.74% | 14.31% | +21.43% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 39.31% | 14.96% | +24.35% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 37.75% | 16.82% | +20.93% |
BBC vs. FHLC - Expense Ratio Comparison
BBC has a 0.79% expense ratio, which is higher than FHLC's 0.08% expense ratio.
Dividends
BBC vs. FHLC - Dividend Comparison
BBC's dividend yield for the trailing twelve months is around 1.57%, more than FHLC's 1.44% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BBC Virtus LifeSci Biotech Clinical Trials ETF | 1.57% | 1.70% | 1.00% | 0.34% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 2.09% | 0.00% | 0.51% |
FHLC Fidelity MSCI Health Care Index ETF | 1.44% | 1.40% | 1.51% | 1.40% | 1.30% | 1.16% | 1.45% | 1.18% | 1.38% | 1.38% | 1.40% | 2.07% |
Frequently Asked Questions
BBC and FHLC have a correlation of 0.49, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
BBC has higher volatility (11.21%) compared to FHLC (3.97%). In terms of maximum drawdown, BBC dropped -76.85% vs FHLC's -28.76%.
On 10-year performance, FHLC leads with 9.05% vs 7.60% for BBC. On fees, FHLC is cheaper at 0.08% per year. On volatility, FHLC has been the lower-risk option at 3.97%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, FHLC has performed better with a 9.05% return vs 7.60%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
FHLC is cheaper with a 0.08% expense ratio, compared with 0.79% for BBC.
BBC has the higher dividend yield at 1.57%, compared with 1.44% for FHLC.
BBC tracks LifeSci Biotechnology Clinical Trials Index, while FHLC tracks MSCI USA IMI Health Care Index. They also come from different issuers: Virtus Investment Partners and Fidelity. Their fees differ too: 0.79% for BBC and 0.08% for FHLC.
BBC currently has the higher Sharpe Ratio (3.49 vs 0.97), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for BBC and FHLC
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer